ValGenesis, RxCloud Collaborate on Tackling Compliance and Quality Assurance Challenges

Image Credit: Adobe Stock Images/Looker_Studio.com

ValGenesis Inc., a software platform company that specializes in enterprise validation lifecycle management systems (VLMS), and RxCloud, a consulting and systems integration organization, are collaborating on tackling quality assurance and compliance obstacles in the life sciences space.

RxCloud offers process consulting services in order to recognize gaps and opportunities. Once it does so, it then suggests potential options to handle these difficulties; the company focuses on the pharmaceutical, medical device, and biotechnology industries.

As for ValGenesis, it is often known by the industry for its end-to-end digital validation platform, featuring its flagship VLMS services. Via the offering, companies in the space are able to implement standardization efforts, facilitate greater compliance, and continue to push for digital transformation across the manufacturing operations departments.

Achieving these objectives would come in the form of meeting FDA, ISO, and GAMP regulatory requirements and standards for quality and safety in the drug development and manufacturing lifecycle.

"In today's fast-paced market, digital validation technology is becoming critical to enable the production of high-quality, competitive, value for money products for patient safety," says Bo Olsen, ValGenesis' SVP of partners. "ValGenesis and RxCloud will enhance processes, procedures, technologies, and environments to help life sciences companies get their products to market more safely and efficiently."

Providing a safe product, albeit a necessary requirement, is a challenge that is easier said than done, especially in today’s constantly evolving marketplace.

"Time is increasingly becoming critical to the life sciences industry. Bringing a safe product to market, meeting changing market demands, and improving operational efficiency is key to the success of every business. By reducing process and procedural overheads, customers get more time to focus on the quality of their product," notes Arjun Vegesna, RxCloud's director & client partner. " … The platform digitizes the end-to-end validation process across the value chain, and we at RxCloud will help you drive this transformation.”

Reference

ValGenesis and RxCloud Announce Strategic Partnership. ValGenesis. February 13, 2024. Accessed February 19, 2024. https://www.valgenesis.com/news/valgenesis-and-rxcloud-announce-strategic-partnership